Ambiq Micro, Inc. (NASDAQ:AMBQ) disclosed that its Chief Technology Officer and Director, Scott McLean Hanson, sold common stock valued at $421,942 on September 15, 2026. The transactions, which also involved the exercise of stock options, were executed under a Rule 10b5-1 trading plan that Hanson adopted on May 15, 2026. The sale arrives as AMBQ shares have climbed 42.9% over the past week and 79% over the past year, changing hands at $50.33 and giving the company a market capitalization of $1.25 billion.
Hanson disposed of 7,000 shares of Ambiq Micro common stock through a series of transactions at prices ranging from $58.93 to $61.00 per share. The breakdown of the sales is as follows:
- 1,953 shares sold at a weighted average price of $59.5339, with individual sale prices between $58.93 and $59.88.
- 4,947 shares sold at a weighted average price of $60.5564, with prices ranging from $59.97 to $60.82.
- 100 shares sold at a price of $61.00 each.
Following these sales, Hanson directly holds 221,226 shares of common stock.
In a concurrent transaction, Hanson exercised options to acquire 7,000 shares of common stock at an exercise price of $8.12 per share, for a total of $56,839. These options had a vesting schedule that began on August 16, 2019, with a quarter of the shares vesting at that time and the remainder vesting in equal monthly installments thereafter, subject to his continued service. After the exercise, Hanson directly holds 45,279 derivative securities (stock options).
According to an analysis, AMBQ currently appears overvalued relative to its Fair Value. For deeper insights into AMBQ’s valuation and comprehensive analysis, investors can access the detailed Pro Research Report available exclusively on InvestingPro.
In other recent news, Ambiq Micro reported impressive third-quarter fiscal 2026 results, with revenue reaching $38.14 million, marking a 110% increase from the same period last year. The company’s adjusted loss per share was significantly better than expected, narrowing to $0.05 compared to the forecasted loss of $0.33. Ambiq Micro’s gross margin also improved, rising by 390 basis points to 48.7% from the previous year. The company anticipates its full-year revenue to hit approximately $140 million, surpassing earlier projections. Despite these strong financial results, shares experienced a slight decline in premarket trading.
Stifel maintained a Buy rating on Ambiq Micro but lowered its price target from $85 to $70, citing broader weakness in the chip sector. The company ended the quarter with a robust cash position of $363.5 million and no debt, highlighting its financial stability. Ambiq Micro’s results were driven by growth across various customers, product families, and form factors, with increased volumes and average selling prices contributing to the revenue surge.